Ceria‐based therapeutic antioxidants for biomedical applications
The growing interest in nanomedicine over the last 20 years has carved out a research field
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …
Redox active cerium oxide nanoparticles: current status and burning issues
Research on cerium oxide nanoparticles (nanoceria) has captivated the scientific community
due to their unique physical and chemical properties, such as redox activity and oxygen …
due to their unique physical and chemical properties, such as redox activity and oxygen …
miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses
AS Doghish, HAM Moustafa, MS Elballal… - … -Research and Practice, 2023 - Elsevier
Retinoblastoma (RB) is a rare tumor in children, but it is the most common primitive
intraocular malignancy in childhood age, especially those below three years old. The RB …
intraocular malignancy in childhood age, especially those below three years old. The RB …
[HTML][HTML] A nano-predator of pathological MDMX construct by clearable supramolecular gold (I)-thiol-peptide complexes achieves safe and potent anti-tumor activity
S Yan, J Yan, D Liu, X Li, Q Kang, W You, J Zhang… - Theranostics, 2021 - ncbi.nlm.nih.gov
As alternatives to small-molecular proteolysis-targeting chimeras (PROTAC), peptide-based
molecular glues (MG) are a broad range of dual-functional ligands that simultaneously bind …
molecular glues (MG) are a broad range of dual-functional ligands that simultaneously bind …
GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision
Retinoblastoma (RB) is a pediatric retinal tumor that overexpresses the ganglioside GD2.
Although it is treatable in patients with early diagnosis, patients may lose one or two eyes …
Although it is treatable in patients with early diagnosis, patients may lose one or two eyes …
Ocular nanomedicine
Intrinsic shortcomings associated with conventional therapeutic strategies often compromise
treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile …
treatment efficacy in clinical ophthalmology, prompting the rapid development of versatile …
[HTML][HTML] Multi-functionalized nanomaterials and nanoparticles for diagnosis and treatment of retinoblastoma
Retinoblastoma is a rare type of cancer, and its treatment, as well as diagnosis, is
challenging, owing to mutations in the tumor-suppressor genes and lack of targeted …
challenging, owing to mutations in the tumor-suppressor genes and lack of targeted …
A Ce-MOF@ polydopamine composite nanozyme as an efficient scavenger for reactive oxygen species and iron in thalassemia disease therapy
Y Duan, L Liang, F Ye, S Zhao - Nanoscale, 2023 - pubs.rsc.org
Patients with β-thalassemia are prone to complications such as cardiovascular diseases and
secretory gland injury due to iron overload (IO) and reactive oxygen species (ROS) …
secretory gland injury due to iron overload (IO) and reactive oxygen species (ROS) …
Efficacy of green cerium oxide nanoparticles for potential therapeutic applications: Circumstantial insight on mechanistic aspects
Green synthesized cerium oxide nanoparticles (GS-CeO2 NPs) have a unique size, shape,
and biofunctional properties and are decorated with potential biocompatible agents to …
and biofunctional properties and are decorated with potential biocompatible agents to …
Green light‐triggered intraocular drug release for intravenous chemotherapy of retinoblastoma
Retinoblastoma is one of the most severe ocular diseases, of which current chemotherapy is
limited to the repetitive intravitreal injections of chemotherapeutics. Systemic drug …
limited to the repetitive intravitreal injections of chemotherapeutics. Systemic drug …